PRECIGEN, INC. 4

CFO Harry Thomasian Jr. sold 100,000 shares of Precigen, Inc. common stock at a weighted average price of about $6.06 per share under a 10b5-1 plan.

On July 31, 2026, Precigen, Inc. Chief Financial Officer Harry Thomasian Jr. reported the sale of 100,000 shares of Precigen common stock at a weighted average price of approximately $6.06 per share, for total proceeds of about $606,000, under a pre-arranged Rule 10b5-1 trading plan. Following this disposition, he reported direct ownership of 254,535 shares of Precigen common stock. The sale was executed in multiple trades within a price range of $6.00 to $6.15 per share, and the filer has undertaken to provide detailed trade breakdowns upon request to the issuer, its security holders, or the SEC staff.

Filing Facts

CIK

1356090

Ticker

PGEN

Form

4

Source Type

fda

Accession

0000950103-26-011578

Alert Tier

6